the maintenance of acid-base balance with reinfusion of endogenous bicarbonate. Background. Uncoated adsorbent charcoal may regenerate the ultrafiltrate suggesting its use as an endogenKey words: charcoal sorbent; haemodiafiltration; ous substitution fluid. The objective of this study was paired filtration dialysis; replacement fluid; ultrafiltrate to assess the safety and the long-term clinical results. Methods. Thirty-three chronic uraemic patients were dialysed for 1 year using two haemodialysers in series in order to separate convection from diffusion. At the Introduction outflow of the convective haemofilter, a cartridge containing 130 g of uncoated charcoal was inserted. The
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Since the early 1970s, the technique of haemoregenerated ultrafiltrate was then infused at the diafiltration has existed as an alternative to haemoentrance of the diffusive dialyser. Ex vivo and in vitro dialysis [1, 2] . studies were performed to analyse the adsorption charWith convective procedures such as haemofiltration acteristics and the release of aluminium, other trace or haemodiafiltration, a certain amount of replaceelements, and microparticles. ment fluid is required. This implies costs, technical Results. Passage through the charcoal left urea, phossurveillance, and risks associated with exogenous fluid phate, potassium, calcium, and bicarbonate concentrainfusion (endotoxins, pyrogens, trace elements) or tions unchanged. Creatinine, uric acid and b 2 -contamination. Several strategies have been developed microglobulin were almost completely absorbed by the such as on-line production of sterile bicarbonate charcoal. Aluminium release was dependent upon time infusate [3] or sorbent regeneration of ultrafiltrate in of storage, as inferred from studies on inter-lot variabilhaemofiltration [4 ] . ity. Washing with bicarbonate buffer ( pH 7.0) allowed A technique for ultrafiltrate regeneration was reduction of aluminium levels to within the pharmacodeveloped using a modified haemodiafiltration techpoeia requirements for intravenous fluids. No significnique by passing ultrafiltrate through a cartridge ant pre-or post-charcoal differences were observed for containing uncoated charcoal [5] [6] [7] [8] . The present study several trace elements such as manganese, selenium, was designed to assess the safety and long-term clinical arsenic, cadmium, mercury, lead, chromium and zinc. results in a large population. Copper was completely retained in the charcoal. Regenerated ultrafiltrate infused at the entrance of the diffusive dialyser was free of microparticles, bacteria, Subjects and methods and endotoxin. Clinical tolerance was excellent and blood pressure control satisfactory. A significant Patients decrease in serum values of b 2 -microglobulin was observed at 6 and 12 months of treatment.
( 18 patients), acetate-free biofiltration with AN69 (3 saline). Trace elements (aluminium, manganese, copper, cadmium, zinc, arsenicum, mercury and lead) were assessed in patients), bicarbonate haemodialysis (12 patients, 9 on cellulosic, 2 on polysulphone, and 1 patient on polyacrylonitrile ex vivo and in vivo conditions. Aluminium concentrations ( mg/l ) and the totally released mass were studied on four membranes). Mean duration of haemodialysis sessions before the study was 3.4±0.3 h. charcoal cartridges from two different lots ( lot 941531 and lot 941532, eight experiments in duplicate) of the same year of production ( 1994) , in order to assess inter-lot variability.
On-line regeneration of ultrafiltrate
Furthermore, charcoal samples from lots produced in three different years (1992, 1993, 1994 ) were tested both for the The sessions were performed three times a week for a 1-year aluminium concentration in the storage solution and in 12 period. Duration was prolonged to achieve a Kt/V>1. A litres of ultrafiltrate recirculated for 1 h a 37°C following double-chamber haemodialyser consisting of 0.55 m2 washing with saline in the single-pass mode. The charcoal high-permeability polysulphone membrane as a convective cartridges were used only once. dialyser and 1.6 m2 diethyl-amino-ethyl-substituted cellulose ( HemophanA) membrane as a diffusive dialyser was used Endogenous substitution fluid Bellco S.p.A., Mirandola, Italy) . Dialysate and blood flows were 500 ml/min and over 300 ml/min (mean±SD Glucose, uric acid, bicarbonate, phosphate, calcium, urea, 305±20 ml/min) respectively. The ultrafiltration rate in the creatinine were analysed by standard methods in the preconvective dialyser was 40-50 ml/min. The composition of and post-charcoal ultrafiltrate obtained in four patients the dialysate was Na 139 mmol/l, K 1.5 mmol/l, HCO 3 every 30 min. 39 mmol/l, and Ca2+ 1.5 mmol/l. Dialysate aluminium conUsing an atomic adsorption method, we studied trace centration in all six Centres was <5 mg/l and remained so element (chromium, manganese, selenium, copper, zinc, during the 1-year period. A disposable cartridge containing arsenicum, cadmium, mercury) concentrations in the ultrafil-130 g of uncoated c-sterilized charcoal cartridge (Detoxyl, trate at the inlet and outlet of the charcoal cartridge at 0, Bellco, Mirandola, Italy), followed by a cellulose acetate 15, 30, 60, 120 and 180 min in 12 sessions before starting the microfilter of 0.8 mm to avoid the release of microparticles clinical trial (regenerated ultrafiltrate was not used as replacewere inserted on the ultrafiltrate line ( Figure 1 ). After pasment fluid). Aluminium concentrations in pre-and postsage through the charcoal cartridge, the ultrafiltrate was charcoal ultrafiltrate were studied in 12 patients. reinfused between the two dialysers in series. In all cases, the cartridges had been buffered with a solution containing CaCl 2 20 mM/l and MgCl 2 10 mM/l with addition of Release of microparticles
To ascertain the dependency of aluminium release on the pH, a bicarbonate-buffered (pH 7 ) solution In vitro experimental studies were performed before starting was used instead of the acetic acid. Immediately before use, therapy in order to investigate the release of microparticles the cartridge was washed with 2 litres saline solution to from charcoal. Fourteen liters of sterile saline solution eliminate the storage solution (sterile, pyrogen-free isotonic (200 ml/min) were filtered through a 0.8, 0.45 or 0.2 mm microfilter at the outlet of the cartridge and collected for the study. The average count of particles (number/ml ) determined by the Coulter method was determined and compared to the pharmacopoeia requirements for intravenous fluids (9 ).
Assessment of sterility and pyrogen content
Six samples (5 ml ) of the filling saline solution of each cartridge were aseptically drawn. Three samples were placed in thioglycollate and the other three in Sabouraud liquid broth, and observed for any bacterial or fungal growth during a 10-day period.
Pre-and post-charcoal ultrafiltrate samples were collected at 1 h and 3 h in sterile tubes for bacteriological assays in six patients. Standard blood culture methods were used for the study.
Pyrogen content
To study the pyrogen content of substitution fluid, we examined the ultrafiltrate obtained during haemodiafiltration (1 and 3 h) pre-and post-charcoal in five patients. Samples were collected in sterile endotoxin-free tubes (Bio-Whittaker, Walkersville, Maryland, USA) refrigerated immediately and sent to the laboratory for assays of endotoxin. Tests were performed using the limulus amoebocyte lysate endotoxin assay system (Chromogenix AB. Molndal, Sweden) with a Results production lots, P<0.005). As shown in Table 3 differences between pre-and post-charcoal ultrafiltrate Studies on the ultrafiltrate concentrations of aluminium in 12 sessions were at all time intervals within AAMI standards (10 mg/l; see As shown in Table 1 , glucose, urea, phosphate, potaslegend to Table 2 ) for infusion fluids. Inter-lot variabilsium, calcium, and bicarbonate concentrations were ity in post-charcoal aluminium concentrations was left unaltered by the charcoal. The charcoal almost tested in ex vivo conditions using 4 charcoal cartridges totally retained creatinine, uric acid and b 2 -of 2 different production lots. Results were microglobulin.
19.5±5.0 mg/l and 5.1±6.9 mg/l at 5 min and 3 h As illustrated in Table 2, aluminium concentrations respectively for lot 941531, and 22.3± mg/l and 7.8±5.8 mg/l at 5 min and 3 h respectively for lot by the Coulter method never exceeded 1000/ml (for Table 3 . The pH dependency of aluminium release was studied after passing ultrafiltrates (mean basal aluminium concentration 27.1±5.6 mg/l ) in a single-pass mode for 5 min and then in a recirculated mode for 1 and 4 h at 50 ml/min at room temperature. Two washing conditions were used on three different production lots: CaCl 2 20 mM/l and MgCl 2 10 mM/l with addition of CH 3 COOH 1% or bicarbonate-buffered solution (pH 7.0 ). *P<0.05, **P<0.001. Endotoxin was studied by the LAL assay (see Subjects and methods) pre-and post-charcoal at 1 and 3 h. AAMI standards for infusion fluids <0.125 EU/ml. microparticles greater than 2.0 mm or 100/ml (for mic-presents the results of the study to identify endotoxin in the ultrafiltrate pre-and post-charcoal. The postroparticles greater than 5.0 mm) (data not shown). These results were obtained with differents lots and charcoal regenerated ultrafiltrate remained free of endotoxin in all samples during the procedure (<0.05 showed that with an 0.8 mm filter the regenerated ultrafiltrate met the pharmacopoeia requirements for EU/ml ). large volume intravenous injection [9 ] .
Patient biochemical data Assessment of sterility and pyrogen content
All biochemical data are shown in Table 6 . There were no statistically significant differences before and after All bacteriological studies both in the storage saline solution and in ultrafiltrate pre-and post-charcoal the use of regenerated ultrafiltrate as a substitution fluid after 1 year of therapy. There was a positive were negative for bacterial or fungal counts. Table 5 Table 6 . Biochemical and dialysis adequacy data during haemodiafiltration with regenerated ultrafiltration as replacement fluid bicarbonate balance with 21±2 predialysis and subjective assessment was positive for all patients (Figure 3 ) . No pyrogenic reactions were observed 27±2 mmol/l postdialysis with regenerated ultrafiltrate concentrations of 25 mmol/l. Kinetic data showed throughout the study. Patient body temperatures did not show significant inter-individual differences among Kt/V and PCr unchanged with means in the range of adequate dialysis ( Kt/V>1). Calcium, phosphate, and patients. No changes were observed in medication through the study. intact PTH were not significantly different. Serum aluminium levels were unchanged. There was a significant decrease in serum b 2 -microglobulin at 6 months Discussion (P<0.05) which persisted after 1 year of treatment (P=0.02). Mean duration of the therapy was 3.2±0.2 h per dialysis session.
In the present study we show that ultrafiltrate after passage through a charcoal-filled cartridge is a safe endogenous replacement fluid. This was based on the Clinical tolerance following lines of evidence. First, although aluminium Dialysis-related symptoms and episodic hypotension could be released from the charcoal, its concentrations were not significantly different despite a higher ultrafil-were always within the upper limit of AAMI standards. tration rate in the diffusive haemodialyser with char-Analysis of the inter-lot variability showed a rapid but coal since the ultrafiltrate was completely reinfused to modest increase in aluminium concentration in the the patient (Figure 2 ). Blood pressure control was post-charcoal ultrafiltrate in the first 5 min. No signisatisfactory (mean predialysis 145/75 and postdialysis ficant variations in pre-versus post-charcoal ultrafil-140/75 mmHg). No particular complaints were noted trate aluminium concentrations could be observed in in patients either during or between sessions and different patients (i.e. ultrafiltrates with different com- Fig. 2 . Intradialytic complications before and after completion of Fig. 3 . Interdialytic symptoms before and after completion of the 1-year study period with charcoal regeneration of ultrafiltrate in the 1-year study period with charcoal regeneration of ultrafiltrate in PFD. Numbers indicate patients in whom the given complication PFD. Numbers indicate patients in whom the given symptom was referred to in the follow-up form during the last month before and was referred to in the follow-up form during the last month before and after the study period.
after the study period.
Regenerated ultrafiltrate as replacement fluid 533 position). An interesting alternative came, however, have been another source of bacteraemia or endotoxin ultrafiltrate contamination. Although no febrile or from studies aimed at evaluating the relationship between acidification or alkalinization as ways to pyrogenic reaction were recorded during the study period of the haemodiafiltration with regenerated ultramodify the releasability of aluminium by the charcoal. The solubility curve of aluminium (% ionized) is filtrate as replacement fluid, Watzke et al. [12 ] reported the absence of febrile reactions despite a mean U-shaped and is consistently dependent on pH, with a steeper rising curve as the pH is shifted away from endotoxin concentration of 115 pg/ml in the dialysis patients' plasma. neutrality [10] . Because of the amphoteric nature of aluminium, a highly water-insoluble aluminium Bacteriological studies and measurements of ultrafiltered endotoxins have shown that regenerated ultrahydroxide is formed at near neutral pH [11 ] . The present in vitro studies have shown a slight initial filtrate was bacteria-and endotoxin-free (<0.05 EU/ml ), thus meeting the pharmacopoeia requireincrease of aluminium at low pH (lower than 5.0) using acetic acid. Washing the cartridge with 2 litres ments for intravenous injection.
The reinfusion of a sterile and pyrogen-free fluid of a bicarbonate-enriched saline solution (pH 7.0) avoided the release of aluminium from the charcoal could have an impact on the overall biocompatibility of the dialysis system and possibly on reducing b 2 -and, more importantly, eliminated the relevant interlot variability as seen in the first 5 min of perfusion. microglobulin generation. Although a significant decrease in serum values of b 2 -microglobulin was seen These results are in agreement with studies performed by Branger and co-workers [10] on the variation of at 6 months and was even more pronounced at 1 year, it is unlikely that removal per se can attain a net aluminium solubility with pH. Secondly, the release of microparticles was always below the upper limit by the balance. In fact, synthesis of b 2 -microglobulin is approximately 3.1±0.79 mg/kg/day in uraemic ruling Pharmacopoeia. As emphasized by Shaldon et al. [4] in early trials using charcoal the very high haemodialysis patients [13 ] , reaching 1500 mg/week.
Based on the observations of this study, the complete aluminium levels (400±100 mg/l after the charcoal ) that these authors reported were related to the passage adsorption of ultrafiltrated b 2 -microglobulin may result in the removal of approximately 145 mg/session into the patient of large charcoal aggregates. The refinement of charcoal production together with the and of 450 mg/week. As comprehensively summarized by Koch [13] , it is possible to envisage that in our adoption of frits at both heads of the cartridge and of a 0.8 mm filter in the reinfusion line prevent the release study the endogenous generation of b 2 -microglobulin may be negatively influenced by reduced production of microparticles. No significant increases in plasma aluminium levels were detected in any of the patients of cytokines.
Adequate clearances of small molecules with a mean undergoing the study during the whole period of observation. Furthermore, none of the patients had 30 min rebound Kt/V>1 were obtained in the presence of a protein catabolic rate (PCR) higher than 1 g/24 h levels of serum aluminium concentration above 60 mg/l. The latter was recently fixed as the serum aluminium per kg body-weight. Although urea was not adsorbed by the charcoal, reinfusion between the two haemodiaconcentration above which aluminium overload or toxicity should be considered even in asymptomatic lysers allowed its clearance by diffusion. Therefore the convective component of urea removal was consistently patients [11] . No variation in aluminium concentrations in the dialysate (as another potential source of reduced. The Kt/V may be increased by optimizing the diffusive surface. Although a Kt/V of 1.05 was aluminium in haemodialysis patients) was recorded in any of the Centres. Further evidence that aluminium initially thought to represent adequate dialysis, it defines only the lower limit of a minimally acceptable was not released during the study period, was the absence of microcytic anaemia and decreased PTH dialysis prescription. Uncontrolled observations suggest that increasing dialysis to achieve a Kt/V of a levels in any of the patients [4, 10] .
Finally, at variance with other sorbent regenerative least 1.3 is associated with improved survival [14, 15] . However, prospective and randomized studies about systems used in the past, where aluminium oxide or other alumina salts were added, the uncoated charcoal haemodiafiltration with increased extraction rate of high-molecular-weight solutes compared to haemodiaused in this study had no aluminium-containing additives. Likewise there was no release of other trace lysis have not been widely performed, and the Kt/V target for adequate dialysis could not necessarily be elements such as manganese, zinc, cadmium, copper, chromium, arsenicum, mercury, lead, or selenium. the same for both modes of therapy. It is also noteworthy that charcoal proved to be effective in removing Bacteraemia and pyrogenic reactions have been described during chronic haemodialysis therapy. small-molecular-weight 'uraemic' compounds during the whole duration of treatment. High-performance Bacterial contamination of the dialysate associated with the introduction of high-flux haemodialysers with chromatographic studies on the ultrafiltrate UV profiles at the start and at different time intervals during more permeable membranes has caused concern that bacteria, endotoxin, or other bacterial products in the treatment showed the complete adsorption by the charcoal of uric acid, pseudouridine, and other unredialysate could pass more readily across the dialyser membrane into the patients' bloodstream.
cognized 'uraemic' peaks for as long as 240 min at 50 ml/min flow rate through 130 g of uncoated charcoal In this study charcoal cartridge contamination could
